The threat of the carbapenemase-producing enterobacteriaceae in Spain: Positioning report of the SEIMC study groups, GEIH and GEMARA;La amenaza de las enterobacterias productoras de carbapenemasas en España: Documento de posicionamiento de los grupos de estudio GEIH y GEMARA de la SEIMC

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue 10, 2014, Pages 666-670

  Oteo, Jesús ^a,b   Calbo, Esther ^b,c,d   Rodríguez Baño, Jesús ^b,e,f   Oliver, Antonio ^f,g   Hornero, Ana ^b,i   Ruiz Garbajosa, Patricia ^b,j   Horcajada, Juan Pablo ^b,k   Del Pozo, José Luis ^b,l   Riera, Montserrat ^b,c   Sierra, Rafael ^b,m   Bou, Germán ^h,n   Salavert, Miguel ^b,o  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Grupo de Estudio de la Infección Hospitalaria   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

^d UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f UNIVERSITY OF SEVILLE   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h Grupo de Estudio de los Mecanismos de Acción y de la Resistencia a Antimicrobianos   (Spain)

ⁱ HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k HOSPITAL DEL MAR   (Spain)

^l UNIVERSITY CLINIC OF NAVARRA   (Spain)

^m HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

ⁿ HOSPITAL JUAN CANALEJO   (Spain)

^o HOSPITAL UNIVERSITARIO LA FE   (Spain)

more..

Author keywords

Carbapenemases

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEMASE; CARBAPENEMASE OXA 48; CARBAPENEMASE VIM 1; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; HEALTH CARE SYSTEM; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; NONHUMAN; SPAIN; DRUG RESISTANCE; EXTENSIVE DRUG RESISTANCE; HEALTH HAZARD; HUMAN; INFECTION RISK; MULTIDRUG RESISTANCE; BIOSYNTHESIS; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; SPAIN;

EID: 84927693072     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2014.02.011     Document Type: Article

References (49)

1. Oteo J, Pérez-Vázquez M, Campos J. Extended-spectrum beta-lactamase producing Escherichia coli: Changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010; 23: 320-6.
2. Miró E, Agüero J, Larrosa MN, Fernández A, Conejo MC, Bou G, et al. Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis. 2013; 32: 253-9.
3. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: Conclusions from a meeting of national experts. Euro Surveill. 2010; 1: 5.
4. Walsh TR Emerging carbapenemases: A global perspective. Int J Antimicrob Agents. 2010; 36:S8-14.
5. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: The quiet before the storm. Clin Microbiol Rev. 2005; 18: 306-25.
6. Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J, European NDM-1 Survey Participants. New Delhi metallo-β-lactamase 1-producing Enterobacteriaceae: Emergence and response in Europe. Euro Surveill. 2010; 15, pii: 19716.
7. Queenan AM, Busk K. Carbapenemases: The versatile β-lactamases. Clin Microbiol Rev. 2007; 20: 440-58.
8. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17: 1791-8.
9. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al. Acquired carbapenemasas in Gram-negative bacterial pathogens: Detection and surveillance issues. Clin Microbiol Infect. 2010; 16: 112-22.
10. Voulgari E, Poulou A, Koumaki V, Tsakris A. Carbapenemase-producing Enterobacteriaceae: Now that the storm is finally here, how will timely detection help us fight back. Future Microbiol. 2013; 8: 27-39.
11. Cantón R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012; 18: 413-31.
12. Glasner C, Albiger B, Buist G, Tambic Andrasevic A, Canton R, Carmeli Y, et al. Carbapenemase-producing Enterobacteriaceae in Europe: A survey among national experts from 39 countries. Euro Surveill. 2013; 18: pii: 20525.
13. Sánchez-Romero I, Asensio A, Oteo J, Muñoz-Algarra M, Isidoro B, Vindel A, et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: Molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother. 2012; 56: 420-7.
14. Tato M, Coque TM, Ruíz-Garbajosa P, Pintado V, Cobo J, Sader HS, et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-betalactamase in Spain: Toward endemicity. Clin Infect Dis. 2007; 45: 1171-8.
15. Pitart C, Solé M, Roca I, Fàbrega A, Vila J, Marco F. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother. 2011; 55: 4398-401.
16. Oteo J, Hernández JM, Espasa M, Fleites A, Sáez D, Bautista V, et al. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J Antimicrob Chemother. 2013; 68: 317-21.
17. Samuelsen Ø, Naseer U, Tofteland S, Skutlaberg DH, Onken A, Hjetland R, et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother. 2009; 63: 654-8.
18. Potron A, Kalpoe J, Poirel L, Nordmann P. European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect. 2011; 17:E24-6.
19. Lee GC, Burgess DS. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: A review of published case series and case reports. Ann Clin Microbiol Antimicrob. 2012; 11: 32.
20. Oteo J, Hernández-Almaraz JL, Gil-Antón J, Vindel A, Fernández S, Bautista V, et al. Outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J. 2010; 29: 1144-6.
21. Paño-Pardo JR, Ruiz-Carrascoso G, Navarro-San Francisco C, Gómez-Gil R, Mora-Rillo M, Romero-Gómez MP, et al. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak. J Antimicrob Chemother. 2013; 68: 89-96.
22. Cantón R, Bryan J. Global antimicrobial resistance: From surveillance to stewardship. Part 1: Surveillance and risk factors for resistance. Expert Rev Anti Infect Ther. 2012; 10: 1269-71.
23. Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012; 18: 439-48.
24. Petrosillo N, Giannella M, Lewis R, Viale P. Treatment of carbapenem-resistant Klebsiella pneumoniae: The state of the art. Expert Rev Anti Infect Ther. 2013; 11: 159-77.
25. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin Microbiol Rev. 2012; 25: 682-707.
26. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18: 268-81.
27. Tórtola MT, Lavilla S, Miró E, González JJ, Larrosa N, Sabaté M, et al. First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother. 2005; 49: 3492-4.
28. Miró E, Agüero J, Larrosa MN, Fernández A, Conejo MC, Bou G, et al. Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis. 2013; 32: 253-9.
29. Miró E, Segura C, Navarro F, Sorlí L, Coll P, Horcajada JP, et al. Spread of plasmids containing the blaVIM-1 and blaCTX-M genes and the Qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. J Antimicrob Chemother. 2010; 65: 661-5.
30. Cendejas E, Gómez-Gil R, Gómez-Sánchez P, Mingorance J. Detection and characterization of Enterobacteriaceae producing metallo-beta-lactamases in a tertiary-care hospital in Spain. Clin Microbiol Infect. 2010; 16: 181-3.
31. Curiao T, Morosini MI, Ruiz-Garbajosa P, Robustillo A, Baquero F, Coque TM, et al. Emergence of blaKPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother. 2010; 65: 1608-14.
32. Gómez-Gil MR, Paño-Pardo JR, Romero-Gómez MP, Gasior M, Lorenzo M, Quiles I, et al. Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother. 2010; 65: 2695-7.
33. Oteo J, Domingo-García D, Fernández-Romero S, Saez D, Guiu A, Cuevas O, et al. Abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in Spain. J Med Microbiol. 2012; 61: 864-7.
34. Solé M, Pitart C, Roca I, Fàbrega A, Salvador P, Muñoz L, et al. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother. 2011; 55: 4402-4.
35. Gil-Romero Y, Sanz-Rodríguez N, Almagro-Moltóm, Gómez-Garcés JL. New description of a NDM-1 carbapenemase producing Klebsiella pneumoniae carrier in Spain. Enferm Infecc Microbiol Clin. 2012; 31: 418-9.
36. Oteo J, Saez D, Bautista V, Fernández-Romero S, Hernández-Molina JM, Pérez-Vázquez M, et al. Carbapenemase-producing enterobacteriaceae in Spain in 2012. Antimicrob Agents Chemother. 2013; 57: 6344-7.
37. Plan de Prevención y Control frente a infecciones causadas por enterobacterias productoras de carbapenemasas de la Comunidad de Madrid [consultado 20 Feb 2014]. Disponible en: http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-isposition&blobheadername2=cadena&blobheadervalue1=filename%3DPLAN+PREVENCI%C3%93N+Y+CONTROL+EPC+CM-v1sept+2013.pdf&blobheadervalue2=language%3Des%26site%3DPortalSalud&blobkey=id&blobtable=MungoBlobs&blobwhere=1352838664739&ssbinary=true
38. Detección fenotípica de mecanismos de resistencia en gramnegativos. Procedimientos en Microbiología Clínica. Recomendaciones de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. SEIMC, 2011 [consultado 10 Ene 2014]. Disponible en: http://www.seimc.org/documentos/protocolos/microbiologia/.
39. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: Therapeutic approach and infection control. Clin Microbiol Infect. 2010; 16: 102-11.
40. Khan AS, Dancer SJ, Humphreys H. Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals. J Hosp Infect. 2012; 82: 85-93.
41. Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, et al. Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol. 2011; 49: 3986-9.
42. Poulou A, Voulgari E, Vrioni G, Xidopoulos G, Pliagkos A, Chatzipantazi V, et al. Imported Klebsiella pneumoniae carbapenemase-producing Klebsiellapneumoniae clones in a Greek hospital: Impact of infection control measures for restraining their dissemination. J Clin Microbiol. 2012; 50: 2618-23.
43. Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE). CRE Toolkit. National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion. CDC, 2012 [consultado 15 Ene 2014]. Disponible en: http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf
44. Robustillo Rodela A, Díaz-Agero Pérez C, Sanchez Sagrado T, Ruiz-Garbajosa P, Pita López MJ, Monge V. Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiellapneumoniae in Spain. September 2009 to February 2010: Control measures. Euro Surveill. 2012; 17, pii: 20086.
45. Tacconelli E, Cataldo MA, Dancer SJ, de Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014; Suppl 1: 1-55.
46. Landman D, Babu E, Shah N, Kelly P, Olawole O, Bäcker M, et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: Progress and frustration. J Antimicrob Chemother. 2012; 67: 1427-31.
47. Rodríguez-Baño J, Paño-Pardo JR, Alvarez-Rocha L, Asensio A, Calbo E, Cercenado E, et al. Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document. Enferm Infecc Microbiol Clin. 2012; 30: 22e1-23.
48. European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities. ECDC, 2011 [consultado 5 Feb 2014]. Disponible en: http://www.ecdc.europa.eu/en/publications/Publications/110913-Risk-assessment-resistant-CPE.pdf
49. Wernli D, Haustein T, Conly J, Carmeli Y, Kickbusch I, Harbarth S. A call for action: The application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med. 2011; 8:e1001022.